Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹582 Cr
P/E Ratio
69.17
P/B Ratio
2.74
Industry P/E
63.31
Debt to Equity
0.16
ROE
4.94 %
ROCE
8.46 %
Div. Yield
0.22 %
Book Value
166.84
EPS
6.62
CFO
₹22.02 Cr
EBITDA
₹167.48 Cr
Net Profit
₹92.76 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Medicamen Biotech
| -10.54 | -6.93 | -6.92 | 10.83 | -13.08 | -- | -- |
|
BSE Healthcare
| -5.48 | 1.35 | 0.22 | 22.74 | 20.05 | 23.06 | 9.77 |
|
BSE Small Cap
| -10.07 | 4.18 | -3.21 | 7.10 | 18.99 | 35.87 | 15.84 |
|
2024
|
2023
|
2022
|
|
|---|---|---|---|
|
Medicamen Biotech
| -13.33 | -27.38 | -6.43 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 773.40 | 2,500.36 | 33.05 | 9.17 | |
| 1,749.70 | 8,966.31 | 58.9 | 13.35 | |
| 769.20 | 4,085.27 | 46.57 | 17.29 | |
| 1,119.90 | 11,473.71 | 80.86 | 20.53 |
No Review & Analysis are available.
Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India. The company offers a range of products, including tablets, such as non-beta lactam tablets; capsules... comprising beta and non-beta lactam capsules; liquid and dry syrups; and ointments and creams. It also provides oral solid and liquid products. The company's products are used in various therapeutic areas, such as gastrointestinal, pain management, anti-infectives, pediatrics, dermatology, gynecology and rheumatology, diabetology, cardiology, oncology, and the central nervous system. Medicamen Biotech Limited was incorporated in 1993 and is based in New Delhi, India. Read more
Incorporated
1993
Chairman
Rahul Bishnoi
Managing Director
--
Headquarters
New Delhi, Delhi
Website
Looking for more details about Medicamen Biotech Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Medicamen Biotech Ltd stood at ₹ 289 Cr as on 31-Dec-24
The share price of Medicamen Biotech Ltd is ₹458.45 (NSE) and ₹458.95 (BSE) as of 23-Apr-2025 15:45 IST. Medicamen Biotech Ltd has given a return of -13.08% in the last 3 years.
Medicamen Biotech Ltd has a market capitalisation of ₹ 582 Cr as on 23-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Medicamen Biotech Ltd is 2.74 times as on 23-Apr-2025, a 71% discount to its peers’ median range of 9.36 times.
The P/E ratio of Medicamen Biotech Ltd is 69.17 times as on 23-Apr-2025, a 9% premium to its peers’ median range of 63.31 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Medicamen Biotech Ltd and enter the required number of quantities and click on buy to purchase the shares of Medicamen Biotech Ltd.
Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India. The company offers a range of products, including tablets, such as non-beta lactam tablets; capsules comprising beta and non-beta lactam capsules; liquid and dry syrups; and ointments and creams. It also provides oral solid and liquid products. The company's products are used in various therapeutic areas, such as gastrointestinal, pain management, anti-infectives, pediatrics, dermatology, gynecology and rheumatology, diabetology, cardiology, oncology, and the central nervous system. Medicamen Biotech Limited was incorporated in 1993 and is based in New Delhi, India.
The promoter of Medicamen Biotech Ltd is Shivalik Rasayan Limited. Shivalik Rasayan Limited owns 43.16 per cent of the total equity. The chairman of the company is Rahul Bishnoi ..
There is no promoter pledging in Medicamen Biotech Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,711
|
|
|
8,525
|
|
|
3,757
|
|
|
2,592
|
| Medicamen Biotech Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
4.04
|
|
Operating margin(%)
|
7.13
|
|
Net Margin(%)
|
3.67
|
|
Dividend yield(%)
|
0.21
|
Yes, TTM profit after tax of Medicamen Biotech Ltd was ₹8 Cr.
₹-11.00
(
